Carregant...

Evidence for a therapeutic gain when AQ4N or tirapazamine is combined with radiation.

The use of bioreductive drugs as an adjunct to radiotherapy in the treatment of cancer is presently being tested in several clinical trials worldwide. We have developed a novel bioreductive compound AQ4N (1,4-bis-¿[2-(dimethylamino-N-oxide)ethyl]amino¿ 5,8-dihydroxy-anthracene-9, 10-dione) which c...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: McKeown, S. R., Friery, O. P., McIntyre, I. A., Hejmadi, M. V., Patterson, L. H., Hirst, D. G.
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 1996
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2150042/
https://ncbi.nlm.nih.gov/pubmed/8763843
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!